| Literature DB >> 21753741 |
Ying Wu1, Monica Blichowski, Zafiris J Daskalakis, Zhouyou Wu, Chun C Liu, Miguel A Cortez, Orlando Carter Snead.
Abstract
Neurophysiological studies suggest that clozapine may facilitate γ-aminobutyric acid (GABAergic) neurotransmission. Therefore, we studied the interaction between clozapine and the GABAB receptor (GABABR). We showed that clozapine, and not N-desmethylclozapine, which is a metabolite of clozapine, increased the binding of the GABABR antagonist, [³H]-CGP54626A, at GABABRs. Linear regression analysis showed that the correlation between the dose of clozapine and the increase of [³H]-CGP54626A binding was significant. The curve of specific [³H]-CGP54626A binding in competition with different concentrations of GABA was left shifted in the presence of clozapine. With HEK293 cells overexpressing GABABR, we showed that clozapine had a significant increase of [³H]-CGP54626A binding at GABABR1 subunit, which provided a clue of the potential therapeutic target of clozapine. 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21753741 DOI: 10.1097/WNR.0b013e328349739b
Source DB: PubMed Journal: Neuroreport ISSN: 0959-4965 Impact factor: 1.837